A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses
Crossref DOI link: https://doi.org/10.1007/s00280-014-2604-8
Published Online: 2014-10-15
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cohen, E. E. W.
Tortorici, M.
Kim, S.
Ingrosso, A.
Pithavala, Y. K.
Bycott, P.
License valid from 2014-10-15